$77.59
+1.20 (+1.57%)
At Close: Jun 03, 2026
Avis Budget, Zoetis, Palantir Technologies And Other Big Stocks Moving Higher On Tuesday
03:26pm, Tuesday, 14'th Feb 2023 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
SkyWater Technology, Inc. (NASDAQ: SKYT) jumped 20.1% t
Final Trades: Zoetis, Citigroup & Nvidia
02:32pm, Tuesday, 14'th Feb 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Zoetis' (ZTS) Q4 Earnings in Line With Estimates, Revenues Beat
01:33pm, Tuesday, 14'th Feb 2023
Zoetis' (ZTS) fourth-quarter 2022 earnings per share was at par with the Zacks Consensus Estimate, while revenues beat the same. The company provides its financial guidance for 2023.
Zoetis (ZTS) Matches Q4 Earnings Estimates
01:15pm, Tuesday, 14'th Feb 2023 Zacks Investment Research
Zoetis (ZTS) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zoetis Inc. (ZTS) Q4 2022 Earnings Call Transcript
12:51pm, Tuesday, 14'th Feb 2023
Zoetis Inc. (NYSE:ZTS ) Q4 2022 Earnings Conference Call February 14, 2023 8:30 AM ET Company Participants Steve Frank - Vice President, Investor Relations Kristin Peck - Chief Executive Officer Wette
Zoetis (ZTS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
12:03pm, Tuesday, 14'th Feb 2023
The headline numbers for Zoetis (ZTS) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Zoetis (ZTS) Matches Q4 Earnings Estimates
09:47am, Tuesday, 14'th Feb 2023
Zoetis (ZTS) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zoetis Snags A Quarterly Sales Beat And Issues A Strong 2023 Outlook
09:11am, Tuesday, 14'th Feb 2023
Animal health giant Zoetis beat fourth-quarter sales expectations Tuesday and issued a strong 2023 outlook, leading ZTS stock to pop. The post Zoetis Snags A Quarterly Sales Beat And Issues A Strong 2
COLL or ZTS: Which Is the Better Value Stock Right Now?
04:40pm, Monday, 13'th Feb 2023 Zacks Investment Research
COLL vs. ZTS: Which Stock Is the Better Value Option?
3 Stocks to Avoid This Week
01:15pm, Monday, 13'th Feb 2023 The Motley Fool
These investments seem pretty vulnerable right now.
COLL or ZTS: Which Is the Better Value Stock Right Now?
12:48pm, Monday, 13'th Feb 2023
COLL vs. ZTS: Which Stock Is the Better Value Option?
3 Stocks to Avoid This Week
08:15am, Monday, 13'th Feb 2023
These investments seem pretty vulnerable right now.
Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?
01:37pm, Friday, 10'th Feb 2023 Zacks Investment Research
Higher sales of Zoetis' (ZTS) key drugs like Apoquel, Cytopoint, Simparica Trio, Librela and Solensia are expected to have driven sales, partially offset by lower sales of livestock, cattle, poultry a
Zoetis (ZTS) Stock Moves -0.78%: What You Should Know
11:15pm, Thursday, 09'th Feb 2023 Zacks Investment Research
Zoetis (ZTS) closed the most recent trading day at $160.81, moving -0.78% from the previous trading session.
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
03:00pm, Tuesday, 07'th Feb 2023 Zacks Investment Research
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sign In
Buy ZTS